DAVID SANCHEZ: Open Payments
NPI 1316567928 · SHARPSBURG, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,140 in 58 payments from 18 companies in 2025. Trend: 2023 $53 · 2024 $463 · 2025 $1,140
Food & beverage: $1,140
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $207 |
| Novo Nordisk Inc | 9 | $183 |
| PFIZER INC. | 6 | $120 |
| SANOFI-AVENTIS U.S. LLC | 5 | $104 |
| Janssen Pharmaceuticals, Inc | 4 | $99 |
| ABBVIE INC. | 5 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $65 |
| Astellas Pharma US Inc | 2 | $40 |
| Lilly USA, LLC | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $34 |
Products named: FARXIGA, Wegovy, TZIELD, SPRAVATO, AIRSUPRA, XIFAXAN, Veozah, Ozempic.
Industry payments across GA — which companies pay providers there.
